Passive blood anaphylaxis: subcutaneous immunoglobulins are a cause of ongoing passive anaphylactic reaction

Allergy, Asthma & Clinical Immunology

Allergy, Asthma & Clinical Immunology 2017 13:41

https://doi.org/10.1186/s13223-017-0213-x

Przemyslaw Zdziarski, Andrzej Gamian, Jacek Majda and Agnieszka Korzeniowska-Kowal

Abstract
Background
Allergic, especially anaphylactic, reactions during immunoglobulin replacement therapy are rare, but their pathophysiology and classification remain ambiguous. Recent findings show positive results of skin tests with commercially available immunoglobulins, but target antigens and responsible compounds of the tested immunoglobulins have not been strictly identified.

Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children

PloS One 2017, 12 (8): e0182295

Jae Hyun Lim, Jin Youp Kim, Doo Hee Han, Chul Hee Lee, Seung-No Hong, Jee Hye Wee, Sue K Park, Chae-Seo Rhe

INTRODUCTION: The aim of this study is to identify the effects of sublingual immunotherapy (SLIT) on immunologic parameters and bronchial-hyper-responsiveness in children with allergic rhinitis to house-dust mite (HDM), through long-term follow-up cohort.

Comparison of the Performance of Skin Prick, ImmunoCAP, and ISAC Tests in the Diagnosis of Patients with Allergy

Int Arch Allergy Immunol 2017;172:215-223

https://doi.org/10.1159/00046432

Griffiths R.L.M. · El-Shanawany T. · Jolles S.R.A. · Selwood C. · Heaps A.G. · Carne E.M. · Williams P.E. 

Abstract

Background: Allergy is diagnosed from typical symptoms, and tests are performed to incriminate the suspected precipitant. Skin prick tests (SPTs) are commonly performed, inexpensive, and give immediate results. Laboratory tests (ImmunoCAP) for serum allergen-specific IgE antibodies are usually performed more selectively. The immuno-solid phase allergen chip (ISAC) enables testing for specific IgE against multiple allergen components in a multiplex assay.

Dr. Robbie Pesek Discusses Food allergy diagnosis and management

Dr. Robbie Pesek Discusses Food allergy diagnosis and management.

ACAAICOLA

Dr. Phil Lieberman discusses the diagnosis and management anaphylaxis

Dr. Phil Lieberman discusses the diagnosis and management anaphylaxis

ACAAICOLA

The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis

Vaccine

Available online 11 September 2017

In Press, Corrected Proof

Review

Author links open overlay panelCristiano Alicino ChiaraPaganinoAndrea Orsi Matteo Astengo CeciliaTrucchi Giancarlo Icardi Filippo Ansaldi

https://doi.org/10.1016/j.vaccine.2017.09.005Get rights and content

Under a Creative Commons license

open access

Highlights
• Since 2010, PCV10 and PCV13 became available for use in children. 

• This meta-analysis assessed the impact PCV10 and PCV13 in pneumonia hospitalization among children. 

• Novel PCVs reduced hospitalization for pneumonia in children 

• Reduction was more pronounced for radiologically confirmed pneumonia with respect to clinically confirmed pneumonia. 

• None of the studies included in this meta-analysis had been designed to directly compare the impact of PCV10 and PCV13.

Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients

May–June, 2017Volume 5, Issue 3, Pages 779–789.e6

Eli O. Meltzer, MDCorrespondence information about the author MD Eli O. MeltzerEmail the author MD Eli O. Meltzer

, 

Judith Rosen Farrar, PhD

, 

Cary Sennett, MD, PhD

Open Access

PlumX Metrics

DOI: http://dx.doi.org/10.1016/j.jaip.2016.10.010

 |

Article Info

• Abstract

• Full Text
• Images
• References

Background

Seasonal allergic rhinoconjunctivitis (SARC) affects ≥16% of the US population annually. Telephone and in-office surveys have demonstrated negative effects of allergic rhinitis (AR) symptoms on sleep, daily activities, productivity, concentration, and emotions.

Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure

• Springer Open Choice
• PMC5533814

Allergo Journal International

Allergo J Int. 2017; 26(5): 168–193.

Published online 2017 Feb 28. doi:  10.1007/s40629-017-0013-3

PMCID: PMC5533814

S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association of Allergists (AeDA), the German Society of Dermatology (DDG), the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Occupational and Environmental Medicine (DGAUM), the German Society for Hospital Hygiene (DGKH), the German Society for Pneumology and Respiratory Medicine (DGP), the German Mycological Society (DMykG), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Federal Association of Pediatric Pneumology (BAPP), and the Austrian Society for Medical Mycology (ÖGMM)

Gerhard A. Wiesmüller,1,2 Birger Heinzow,3 Ute Aurbach,4 Karl-Christian Bergmann,5 Albrecht Bufe,6 Walter Buzina,7Oliver A. Cornely,8 Steffen Engelhart,9 Guido Fischer,10 Thomas Gabrio,11 Werner Heinz,12 Caroline E. W. Herr,13,14Jörg Kleine-Tebbe,15 Ludger Klimek,16 Martin Köberle,17 Herbert Lichtnecker,18 Thomas Lob-Corzilius,19 Rolf Merget,20 Norbert Mülleneisen,21 Dennis Nowak,22 Uta Rabe,23 Monika Raulf,20 Hans Peter Seidl,24 Jens-Oliver Steiß,25,26 Regine Szewszyk,27 Peter Thomas,28 Kerttu Valtanen,27 and Julia Hurraß2

Author information ► Copyright and License information ►

Abstract

This article is an abridged version of the AWMF mould guideline “Medical clinical diagnostics of indoor mould exposure” presented in April 2016 by the German Society of Hygiene, Environmental Medicine and Preventive Medicine (Gesellschaft für Hygiene, Umweltmedizin und Präventivmedizin, GHUP), in collaboration with the above-mentioned scientific medical societies, German and Austrian societies, medical associations and experts.